Phase III studies of Xolair in chronic rhinosinusitis with nasal polyps meet coprimary endpoints June 3, 2019
Jiangsu Hengrui Medicine's camrelizumab receives first approval in China for treatment of lymphoma June 3, 2019
First phase I results for anti-GITR antibody MK-4166 in patients with advanced solid tumors June 3, 2019
RSS